2024-09-262024-09-262022-11-010268-3369https://hdl.handle.net/11452/45304Bu çalışma, 19-23 Mart 2022 tarihleri arasında Çek Cumhuriyeti’de düzenlenen 48. Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineHematologyImmunologyTransplantationBiophysicsEfficacy of plerixafor plus g-csf in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. a retrospective studyMeeting Abstract00087815330066841241357SUPPL 1, Supplement 1